This webpage was developed by the RSV Alliance. The Alliance is currently supported by GAAAP, IFA, GSK and ESWI who have contributed time and expertise in the development of this content to raise awareness of RSV. All RSV Alliance activities are funded by GSK.

RSV Alliance
What is RSV?
Respiratory Syncytial Virus (RSV) is a common virus that infects the lungs and respiratory tract. It spreads easily and can typically cause cold-like symptoms such as coughing, sneezing, and fever1. Most people recover in a week or two, but RSV can be serious for certain groups.
RSV is one of the main causes of lung infections in babies and young children, and it can lead to bronchiolitis and pneumonia2. Older adults and people with health conditions like heart or lung disease, diabetes, or weak immune systems are also at higher risk for serious illness due to RSV infection3 4 5.
Each year, RSV leads to many hospital stays, especially among older adults and those with chronic health issues6
Why it matters:
- RSV can cause severe respiratory illness, including pneumonia6.
- It spreads easily and affects people of all ages7.
- Older adults and people with underlying health problems like heart or lung disease, diabetes, weak immune systems, serious neurological or metabolic disorders, and crowded living conditions are more likely to get very sick than younger adults or those without certain long term conditions6.
- Complications from RSV can worsen certain existing health conditions or may require hospitalization or may even be life-threatening 6 8.
By raising awareness, the RSV Alliance aims to reduce the impact of RSV on adults most at risk.
Our Mission
We amplify global awareness of RSV and elevate the patient voice through advocacy, education, and strategic partnerships, helping to reduce the impact of RSV on older adults and people living with certain chronic conditions.

Our Vision
A world where adults at risk for RSV understand how to reduce their chances of getting sick, recognize symptoms early, and seek appropriate care.
Our Guiding Principles
- Person-Centered
We place the needs, experiences, and voices of people at risk of RSV at the heart of everything we do.
- Collaborative
We unite patient, scientific and health professional organizations and industry, achieving more together than any group could alone.
- Evidence-Based
Our awareness and advocacy efforts are grounded in the most up-to-date science and data.
- Transparent & Inclusive
We value industry support, including GSK’s role as a core member and funder, and ensure governance and activities are agreed upon by the RSV Alliance.
- Global Yet Local
We support regional and national organizations in adapting RSV strategies to meet community needs.
Social Media Content
Help spread the word about RSV risks by sharing these images on social media.
Our Partners & Supporters
The RSV Alliance is proud to collaborate with organizations committed to improving RSV awareness that share our commitment to improving awareness, prevention, and care for at-risk adults.
Core Members:
- Global Allergy & Airways Patient Platform (GAAPP)
- International Federation on Ageing (IFA)
Industry Core Member and Funder:
- GSK
Scientific Oversight:
- European Scientific Working Group on Influenza (ESWI)
Additional partners and supporters may be listed here as they join the Alliance.
References
- Centers for Disease Control and Prevention (CDC). Symptoms and Care of RSV. Accessed October 2025. https://www.cdc.gov/rsv/symptoms/index.html
- Centers for Disease Control and Prevention (CDC). RSV in Infants and Young Children. Accessed October 2025. RSV in Infants and Young Children | RSV | CDC. Accessed October 2025. https://www.cdc.gov/rsv/infants-young-children/index.html
- World Health Organization (WHO). Respiratory Syncytial Virus (RSV) Fact Sheet. Accessed October 2025. https://www.who.int/news-room/fact-sheets/detail/respiratory-syncytial-virus-%28rsv%29
- Centers for Disease Control and Prevention (CDC). Preliminary Estimates of RSV Burden for 2024–2025. Accessed October 2025. https://www.cdc.gov/rsv/php/surveillance/burden-estimates.html
- Centers for Disease Control and Prevention (CDC). Clinical Overview of RSV. Accessed October 2025. https://www.cdc.gov/rsv/hcp/clinical-overview/index.html
- National Institutes of Health (NIH), National Library of Medicine. Respiratory Syncytial Virus Infection in Older Adults: An Update. Published July 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11193699/
- Centers for Disease Control and Prevention (CDC). How RSV Spreads. Accessed October 2025. https://www.cdc.gov/rsv/causes/
- BMC Medicine. Estimating the Respiratory Syncytial Virus-Associated Hospitalization Burden in Older Adults: A Systematic Review. Published August 2025. https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-025-04249-x
NX-GBL-RSA-WCNT-250002
October 2025





